Sapient Unveils DynamiQ Next-Gen Data Insights Engine for Drug Discovery and Development Sapient, a pioneering leader in multi-omics data generation and clinical insights, has unveiled its next-generation multi-omics and real-world…
Predicta Biosciences Unveils First Molecular Diagnostic for Enhancing Multiple Myeloma Prognosis Predicta Biosciences, a precision oncology company, has officially launched its first Laboratory Developed Test (LDT), GenoPredicta, a cutting-edge diagnostic…
Verily Wins Michael J. Fox Foundation Grant to Build Major Parkinson’s Molecular Dataset In a significant development for neurodegenerative disease research, Verily, the Alphabet-owned precision health technology company, announced today…
Sunflower Therapeutics Announces Sales Agreement with Optimal Biotech Group Sunflower Therapeutics, a public benefit corporation with a mission to transform global access to protein manufacturing capacity, has taken a significant…
Tranont Adds Metabolic Health Expert Dr. Erin Glynn to Advisory Board In a bold move that underscores its continued investment in science-driven wellness and product development, Tranont, a company known…
Glaukos Reports Financial Results for First Quarter 2025 Glaukos Corporation , a global ophthalmic pharmaceutical and medical technology innovator, delivered a powerful performance in the first quarter of 2025, signaling…
Henry Meds Launches Personalized Hormone Therapies for Menopause Relief Henry Meds, a fast-growing innovator in the telehealth sector, announced a major expansion of its healthcare offerings today with the launch…
Pilatus Biosciences Unveils Preclinical Data on CD36 Antibody PLT012 for Liver Cancer Pilatus Biosciences, a biotechnology company dedicated to developing next-generation immunometabolic therapies for cancer, has announced the publication of…
Revelation Biosciences Advances Development of Gemini Therapy for Infections in Severe Burn Patients Revelation Biosciences, Inc. a clinical-stage life sciences company pioneering approaches to rebalancing inflammation to optimize human health,…
FUJIFILM Cellular Dynamics Names Delara Motlagh as Chief Operating Officer In a strategic move to enhance its operational leadership and accelerate the growth of its cutting-edge platforms in induced pluripotent…
Creyon Bio and Eli Lilly Forge Partnership to Develop RNA-Targeted Oligonucleotide Therapies Creyon Bio, Inc., a leader in innovative RNA-targeted therapies, has announced a transformative global licensing and multi-target research…
Xencor Reports Positive Early Data for Anti-TL1A Antibody in Bowel Disease Xencor, Inc. a leading clinical-stage biopharmaceutical company specializing in the development of engineered antibodies for the treatment of cancer…